
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower Monday after Novo Nordisk A/S (NYSE:NVO) terminated its collaboration with the company.
What Happened: Novo Nordisk announced Monday that it will no longer be working with Hims & Hers Health. As a result, the company will no longer have direct access to Wegovy through the NovoCare Pharmacy.